An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference42 articles.
1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013
2. Anticoagulant therapy for percutaneous coronary intervention;Rao;Circ Cardiovasc Intervent,2010
3. 2014 ESC/EACTS Guidelines on myocardial revascularization
4. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008
5. Bivalirudin started during emergency transport for primary PCI;Steg;N Engl J Med,2013
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bivalirudin in acute coronary syndromes;Expert Review of Cardiovascular Therapy;2023-11-07
2. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials;Circulation;2023-10-17
3. Impact of bivalirudin with a post-procedure infusion versus heparin-monotherapy on stent thrombosis and cardiovascular mortality;Coronary Artery Disease;2023-07-28
4. The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention;American Heart Journal;2022-01
5. Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention;PLOS ONE;2021-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3